Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 720 Jul 31 – Oct 28, 2026
- Disclosed funding
- $110.6B 574 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
Medici BrandsCompany profile Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. | $250M | Series B | Foodtech | United States | Investors | |
CapacityCompany profile Capacity combines AI support agents, human-agent assistance, quality checks and conversational analytics in a customer-support platform. Capacity combines AI support agents, human-agent assistance, quality checks and conversational analytics in a customer-support platform. | >$54M | Series ESeries C+ | Enterprise software | United States | Investors | |
BQPCompany profile A physics-acceleration platform that applies quantum and hybrid quantum-classical algorithms to complex engineering simulations and optimization problems. A physics-acceleration platform that applies quantum and hybrid quantum-classical algorithms to complex engineering simulations and optimization problems. | Undisclosed | Strategic investmentUndisclosed | AI | United States | Investors | |
Konko AICompany profile Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. | $6M | FundingUndisclosed | Healthtech | United States | Investors | |
N-Power MedicineCompany profile N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. | $32M | Series B | Healthtech | United States | Investors | |
ArchiveCompany profile A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. | Undisclosed | Growth investmentGrowth | Media & gaming | United States | Investors | |
NewlightCompany profile Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. | $9M | Seed | Climate tech | United States | Investors | |
| TT Typewriter TherapeuticsCompany profile Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. | $56M | Series A | Biotech | United States | Investors | |
Locus RoboticsCompany profile Locus Robotics supplies autonomous mobile robots and LocusONE software to warehouse and distribution operators. Locus Robotics supplies autonomous mobile robots and LocusONE software to warehouse and distribution operators. | $41.6M | Series GSeries C+ | Robotics | United States | Investors | |
ElucidCompany profile Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. | $55M | Series DSeries C+ | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 31, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
55rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
43rounds16led - 3Sequoia Capital
Hex, Warhound, Whop
25rounds7led - 4General Catalyst
Hyperbolic, Re:Build, Provision Labs
24rounds7led - 5Khosla Ventures
Arda Industries, Tolan
24rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.